Investigating how non-tuberculous mycobacterium affects immune responses in tuberculosis.
Non-tuberculous mycobacterium and B cells in the stimulation of ectopic germinal centers and immunological control of pulmonary tuberculosis
This study is looking at how certain bacteria can help boost the immune system's fight against tuberculosis (TB) in the lungs, with the hope of finding better vaccines and treatments for people with TB.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-10895280 on NIH RePORTER |
What this research studies
This research explores the role of non-tuberculous mycobacterium in enhancing the immune response against pulmonary tuberculosis (TB). It focuses on how exposure to these bacteria can stimulate the formation of ectopic germinal centers in the lungs, which are crucial for generating a robust immune response. By studying the interactions between B cells and antigen-presenting cells, the research aims to identify new therapeutic strategies that could improve TB treatment and prevention. Patients may benefit from insights gained into more effective vaccines or therapies for TB.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals at risk for or currently suffering from pulmonary tuberculosis, especially those with multidrug-resistant TB.
Not a fit: Patients who do not have tuberculosis or are not at risk for TB may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of improved vaccines or therapies for tuberculosis, particularly for those with drug-resistant strains.
How similar studies have performed: Previous research has shown promising results in enhancing immune responses through similar approaches, indicating potential for success in this area.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Dutt, Taru S. — Colorado State University
- Study coordinator: Dutt, Taru S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.